Dental industry news: Oragenics CEO to present at investor conference
Dr. John Bonfiglio, President and CEO of Oragenics, will present an overview of the company Jan. 8, 2013, at the Sixth Annual OneMedForum in San Francisc.
TAMPA, Florida--Oragenics has announced Dr. John Bonfiglio, president and CEO of Oragenics, will present an overview of the company Jan. 8, 2013, at the Sixth Annual OneMedForum in San Francisco.
Launched in 2008 by OneMedPlace, OneMedForum runs concurrently with the 31st Annual J.P. Morgan Healthcare Conference and brings together leading investors, strategic partners, and management of emerging life science companies in Asia and North America.
“Oragenics is moving forward on a number of fronts, including our collaboration with Intrexon on novel lantibiotics and our Evora line of oral probiotics for humans and pets,” stated Dr. Bonfiglio.
“The OneMedForum enables Oragenics to share our strategy and growth potential with top institutional investors, business development executives and key opinion leaders in high growth medical technology, health care and life science industries.”
For more information about Oragenics, visit www.oragenics.com.
To comment on this topic, go to http://community.pennwelldentalgroup.com.